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Abstract  
Introduction Global awareness to the importance of natural fibers in vegetables and fruits are still 
generally very low. Indonesian people consume less fibers, which has been associated with the 
development of heart disease. Heart disease has been known as the leading cause of morbidity and 
mortality. Apolipoprotein B (ApoB) is a component of atherogenic particles that can be used as a 
marker for an increased risk of cardiovascular disease. Researches on apoB profile and its 
relationship with fiber intake has provided inconsistent results. This is an article review of the 
current literatures on the relationship between dietary fiber and serum apoB levels. 
Methods: This is an article review of the current literatures on the relationship between dietary 
fiber and apoB. We searched PubMed and Google Scholar using keyword “dietary fibers” and 
“ApoB” to capture meta-analyses, observational and experimental studies. A total of 97 publication 
and abstracts were screened for this review. After careful screening, nine studies were finally 
included. 
Results: Two studies did not find associations between dietary fiber and serum apoB, while other 
seven found the association. Dietary fiber has been reported to be involved in the metabolism of 
serum cholesterol and blood pressure; hence, the deficiency of dietary fiber intake is believed to 
contribute to the epidemic of cardiovascular diseases. Several factors including nutritional status, 
dietary diet pattern, age, gender, physical activity, and smoking habits might influence the 
relationship between dietary fiber and serum apoB. 
Conclusion: More studies are required in the future for better understanding on the effect of 
dietary fiber on the apoB; hence, the risk of cardiovascular diseases. 
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Introduction 
 
Fruits and vegetables are considered in dietary 
guidance because of their high concentrations of 
dietary fiber.1 According to the National Basic 
Health Research (Riskesdas) data in 2013, the 
national average proportion of low fruit and 
vegetable consumption prevalence for Indonesians 
aged 10 years and older was 93.5%. Similarly, the 
Riskesdas data showed the prevalence of 95.5% in 
2018.2 These data suggesting that public awareness 
and knowledge regarding the consumption of dietary 
fiber from vegetables and fruit is considerably very 
low and tend to get worse. According to data from 
the Ministry of Health, the Indonesian population 
consumes fiber 10.5 g/day generally.3 This finding 
indicating that Indonesian met only half of the 
recommended daily fiber intake. Recommended 
fiber requirements based on the Nutrition Adequacy 
Rate (AKG) is 30–38 g/day. These values are also 
lower compared to the mean fiber intake in the UK 
and USA, which are 18 g/day and 16 g/day 
respectively.4 Additionally, the data from the World 
Health Organization (WHO) shows that Indonesians 
consume fruit and vegetables only 34.55 kg per 
year,5 which is less than half the Food Agriculture 
Organization (FAO) recommendation of 73 kg per 
capita per year.6  
Many evidences have directed to the role of 
dietary fibers to prevent the development of several 
chronic diseases such as cancer, type 2 diabetes, 
obesity and cardiovascular.7,8 In respect to the 
cardiovascular disease, dietary fiber has repeatedly 
been reported to be beneficial in reducing serum 
cholesterol and blood pressure; hence, the 
deficiency of dietary fiber intake is believed to 
contribute to the epidemic of cardiovascular 
disease.9 In support, the results of a study indicated 
that consuming fiber 15-29 grams per day is 
sufficient to reduce mortality and the incidence of 
heart attacks and higher intakes of dietary fiber 
could provide even greater protection.10 
Heart disease is a major health problem and cause 
approximately one-third of deaths globally.11 WHO 
data showed that seventeen million people in the 
world are estimated die from heart disease in 2015, 
75 % of which occur in developing countries.12 
Riskesdas data in 2018 shows that 1.5% Indonesians 
suffer from coronary heart disease.13 Over 200 risk 
factors for heart disease have been identified, 
abnormal lipids profile is regarded as the most 
important risk factor.14 Atherogenic dyslipidemia 
characterized by elevated levels of serum 
triglyceride (TG) levels and low-density lipoprotein 
cholesterol (LDL-C) with low levels of high-density 
lipoprotein cholesterol (HDL-C) plays a significant 
role in the development of heart disease.15 Study by 
Sniderman et al.16 highlighted the age-dependent 
association between apoB and  the risk of 
cardiovascular events. ApoB have been proposed as 
a marker to quantitate the atherogenic damage, due 
to the fact that it is the component constituent of the 
atherogenic particles; hence, plasma apoB levels 
reflect the total numbers of atherogenic particles.16 
Study suggested that the apoB is a better candidate 
risk parameter than non-HDL cholesterol for 
identifying a subgroup of individuals with elevated 
cardiovascular risk.17  
There are several factors that affect the 
circulating apoB levels. These factors are divided 
into groups, namely the nutritional and non-
nutritional factors. The nutritional factors including 
nutritional status, dietary fibers, fat, and 
carbohydrates, while the non-nutritional factors are 
age, gender, physical activity, and smoking habits.18 
The dietary fiber can reduce levels of apoB through 
a distinct mechanism for each fiber source. 
Recently, study suggesting that the dietary fiber can 
reduce levels of apoB through gel formation which 
increases food transit time, delays gastric emptying, 
decreases nutrient absorption, and slows digestion.19 
Additionally, study showed that animals fed with 
fibers exhibited increased LDL-ApoB  turnover, 
leading to the upregulation of hepatic LDL receptors 
and trigger faster catabolism and clearance.19  
Decreasing apoB levels due to the dietary fibers 
can result in the reduced risk of cardiovascular 
disease. Research on the effect of soluble fiber on 
lipid profiles has been reported by several 
independent studies. One clinical trial by Ramos et 
al.20 in 116 people with hypercholesterolemia 
showed that apoB levels in the group fed with fiber 
significantly lower after after 12 weeks. Another 
clinical trial in 28,984 Swedish individuals showed 
a significant correlation between dietary fiber intake 
and apolipoprotein B.21 Unfortunately, research on 
the profile of apolipoprotein B and its relationship 
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with fiber intake so far has provided inconsistent 
results. In this manuscript, we provide a systematic 
literature review on the highly variable research 
results on the association between Apolipoprotein B 




This article is a literature review using any meta-
analyses, observational and experimental studies 
that are relevant to this article. According to 
Creswell and Poth, literature reviews are written 
summaries of articles from journals, books, and 
other documents that describe theories and 
information both past and present; organizing 
literature into the topics and documents needed.22 
The type of data used by the author in this study was 
searched from PubMed and Google Scholar using 
the explode function for subgroup terms with 
operators (“and,”or”) for keyword “dietary fibers” 
and “Apolipoprotein B” to capture all meta-
analyses, observational and experimental studies 
that included findings on the relation of dietary 
fibers and apoB. Hand-searching was used to 
identify further potential eligible studies. A total of 
97 publication titles and abstracts were screened for 
this literature review. The inclusion criteria used in 
this study are categorized based on study design, 
specific interventions, participants, and outcome 
assessed. Study designs of evaluations included in 
the review was controlled trials with either a 
randomised crossover or parallel study design with 
an intervention period equal or greater than 14 days. 
The analysis was limited to primary sources of fibre 
for which there were more than 5 trials per type of 
fibre (i.e. for oat products, psyllium, pectin and guar 
gum). Specific interventions included in this review 
were water-soluble dietary fibers from a single 
source, including pectin, oat bran, guar gum, and 
psyllium. Participants included in this review were 
men or women who either healthy, hyperlipidemic, 
obese or diabetic. Outcomes assessed in this review 
were correlation between dietary fiber intake and 
apolipoprotein B. After careful screening, nine 
studies were finally included. The data obtained then 
analyzed by descriptive analysis method. The 
method of descriptive analysis is carried out by 
describing the facts which are then followed by 
analysis with sufficient understanding and 
explanation. 
 




Definition and classification of fibers 
 
Dietary fiber was originally defined as a non-
digestable constituents of the cell wall of the plant.23 
Later on, dietary fiber was determined as any 
component of plant that resistant to hydrolysis by 
human digestive enzymes.24 In 2000, American 
Association of Cereal Chemists (AACC) defined 
dietary fibre as the edible parts of plant or analogous 
carbohydrates that are resistant to digestion and 
absorption in the human small intestine with 
complete or partial fermentation in the large 
intestine. Dietary fiber includes cellulose, 
hemicellulose, lignin, pectins, gums, b- glucan, 
resistant starch, fructans, chitosan and chitin. 
Fibers can be classified according to their type 
and solubility. Based on the type, fiber is divided 
into dietary fiber and functional fiber. Dietary fibers 
include cellulose, hemicellulose, pectin, lignin, 
gum, fructan and resistance starch; while functional 
fibers include cellulose, pectin, lignin, gum, fructan, 
b-glucan, and psyllium. Fiber can also be classified 
based on its solubility into soluble fiber and 
insoluble fiber. Soluble fibers include 
hemicellulose, pectin, gum, b-glucan, and psyllium; 
while insoluble fibers include lignin, cellulose, 
fructans, and polyols.24 
Dietary fiber can be obtained from daily food 
ingredients such as vegetables, nuts, fruit, and 
cereals. The amount and composition of fibers vary 
between food. The fiber content of different food 
sources is listed in Table 1 .24 
 
Recommended daily intake for dietary fibers 
Current dietary guidance recommends that 
Americans consume 14 g of fiber per 1,000 kcal. 
Recommendations for fiber intake for adults and 
children are shown in Table 2. However, most 
Americans only consume about 15 g of fiber per 
day.25 Meanwhile, in Indonesia, recommended fiber 
requirements based on the Nutrition Adequacy Rate 
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(AKG) is 30–38 g/day depend on the age and gender 
of the individual. At 19-29 years of age, it is 
recommended that men consume 37 grams of 
fiber/per day while woman is 32 grams/day. At the 
age of 30-49, 36 grams per day are recommended for 
men while for woman is 30 grams per day. 
Regardless, the Indonesian population consumes 




Structure of the apolipoproteins 
 
The complete amino acid sequence of the ApoB100 
consists of 4536 amino acids with a molecular 
weight of 550 kDa.26 The mature ApoB100 is the 27 
amino acids N-terminal truncated version of the pre-
mature ApoB100 with the molecular mass of 513 
kDa.27 ApoB100 has a globular amino terminal 
domain, which reacts with microsomal triglyceride 
transfer proteins. The apoB gene is located on the 
short arm of chromosome 2. Study have identified 
one hundred twenty-three genetic variants in the 
apoB gene. The apoB100-3,500Arg-Gln affects its 
receptor binding and causes a disorder known as 
familial defective apolipoprotein B-100 (FDB).28 
ApoB100 is synthesized in hepatocytes and it could 
be degraded under certain conditions.29 ApoB is an 
atherogenic component found in VLDL, IDL, and 
Lpa. Therefore, apoB represents the circulating 
atherogenic lipoprotein particles. 
ApoB48 consists of 2152 amino acids with a 
molecular mass of 264 kDa. ApoB100 and apoB48 
are produced from a single gene. ApoB48 is 
generated by cell-specific RNA editing of a CAA 
codon to a premature UAA termination codon and is 
identical to the N-terminal 48% of apoB100.30 
ApoB48 is synthesized by enterocytes, secreted in 
chylomicrons and stored in chylomicron remnant. 
Since one molecule of apoB48 is present in each 
chylomicron particle, it can be used as a marker for 
the chylomicrons.31 Particles smaller than 70–80 nm 
can penetrate blood vessel walls. Therefore, 
chylomicron remains, but not nascent chylomicrons, 
are considered to be atherogenic. Chylomicron 
waste is enriched with ester cholesterol by exchange 
with HDL.32  
 
 
Lipoprotein classes  
 
Insoluble lipids are transported in a complex with 
proteins as lipoproteins by circulatory system. 
Lipoproteins have a central hydrophobic core of non-
polar lipids, consisting of cholesterol esters and 
triglycerides that is surrounded by a hydrophilic 
membrane consisting of phospholipids, free cholesterol, 
and apolipoproteins. Plasma lipoproteins are divided into 
five classes chylomicrons, Very Low Density 
Lipoprotein (VLDL), Low Density Lipoprotein (LDL), 
High Density Lipoprotein (HDL), and lipoprotein.33 
Apolipoproteins regulate and control lipoprotein 
metabolism and lipid transport by acting as ligands for 
lipoprotein receptors, guiding the formation of 
lipoproteins, and serving as activators or inhibitors of 




Lipoproteins are lipid protein particles that carry 
hydrophobic substances in a hydrophilic 
environment of the blood. Lipoproteins are 
classified based on their hydrated density, in an 
ascending order, into chylomicrons, VLDL, IDL, 
LDL and HDL.35 Apolipoproteins or apoproteins are 
proteins that make up lipoproteins, which serve as 
receptor-binding and regulatory proteins. The cores 
of these particles contain hydrophobic molecules 
such as triglycerides (TG) and cholesteryl esters. 
The liver, intestines, spleen, brain and testes 
synthesize apolipoproteins and at their surface 
contain lipoproteins. There are 4 main types of 
lipoproteins, namely Apo A, B, C, and E. One or 
more apolipoproteins make up each lipoprotein 
including apo A is the main apolipoprotein 
constituent of High-density liporotein (HDL), while 
apo B100 is the main apolipoprotein in LDL and can 
also be found on VLDL. Lipoproteins have different 
sizes according to their lipid composition and 
apolipoprotein content. This characteristic changes 
as a result of the reaction of enzymes such as 
lipoprotein lipase (LPL), hepatic triglyceride lipase 
(HTGL), lecithin-cholesterol acyltransferase 
(LCAT) and cholesterol ester transfer protein 
(CETP).36 Apolipoprotein functions to activate and 
regulate enzymes in lipoprotein metabolism, 
maintain the integrity of the lipoprotein complex 
structure, and become ligands for specific cell 
surface receptors. The formation and metabolism of 
lipoproteins is influenced by both the apolipoprotein 
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content and its conformation. Hepatocytes produce 
apoB100 and the small intestine produces apoB48 
which is a glycoprotein of the apo B group.37 
Apolipoproteins control cellular intake of 
lipoproteins by binding with lipoprotein receptors. 
ApoB100 and apolipoprotein E (apoE) bind to the 
apoB/E (LDL) receptor. ApoE also binds to LDL 
receptor-related protein (LRP). Apolipoprotein A 
binds to the BI scavenger receptor.35 
The exogenous lipoprotein pathway starts with the 
absorption of the dietary cholesterol and fatty acids 
in the intestine, and incorporation into 
chylomicrons. Chylomicrons enter the circulation 
and travel to peripheral sites. Chylomicrons are 
triglyceride-rich and normally catabolized within 
minutes by the endothelium-associated lipoprotein 
lipase (LPL), releasing free fatty acids (FFA), which 
are taken up and metabolized by the liver, muscle, 
and adipose tissues; and chylomicron remnants are 
formed. Chylomicron remnants are then taken up by 
the liver. via the low-density lipoprotein (LDL) 
receptor and the LDL receptor–related protein 
(LRP).33,35,38 
The endogenous lipoprotein pathway begins in 
the liver with the assembly and secretion of 
triglyceride-rich VLDL particles, which transport 
triglycerides from the liver to peripheral tissues. The 
triglycerides carried in VLDL are hydrolysed by 
LPL in muscle and adipose to form intermediate-
density lipoproteins (IDL) or VLDL remnants, 
which can be taken up by the liver or can be further 
hydrolyzed to LDL particles. LDL is converted to 
bile acids in the liver, then secreted into the 
intestines; while in non-hepatic tissues, LDL is used 
for the synthesis of hormones, cell membrane, or 
being stored. LDL is also taken up by macrophages. 
35,38 
LDL transports cholesterol to hepatocytes and 
other peripheral tissues with the help of ApoB100 
for the recognition and uptake of LDL by the LDL 
receptor. Meanwhile, the oxidized LDL (ox-LDL) is 
taken up by macrophages and vascular smooth 
muscle cells. These can lead to excess accumulation 
and the formation of foam cells, which is a major 
step in the plaque formation and development of 
atherosclerosis.39 The small dense LDL cholesterol 
(sdLDL-c) is one of LDL  subclass associated with 
raised TG and decreased HDL-c levels and more 
atherogenic than larger LDL particles.40  
HDL plays a crucial role in reverse cholesterol 
transport, acting as a vehicle for cholesterol shuttle 
from peripheral cells to the liver for excretion and 
catabolism which occurs in three phases: 
extravascular, intravascular, and intrahepatic.41 It 
also provides a reservoir of C apolipoproteins, which 
are required for the metabolism of chylomicrons and 
VLDL. Reverse cholesterol transport can be 
performed in three different routes: (1) HDL with 
multiple apoE is taken up by the liver mediated by 
LDL receptor, (2) accumulated cholesteryl esters 
from HDL is taken up by the liver via the scavenger 
receptor B1, (3) cholesteryl esters are transferred by 
the cholesteryl ester transfer protein (CETP) from 
HDL to triglyceride-rich lipoproteins.42 Many 
experimental and epidemiologic studies have 
indicated the protective effect of HDL against 
atherogenesis indicates its function in reverse 
cholesterol transport. Disturbances in the 
metabolism of lipoproteins is a major contributor of 
the antiatherogenic properties of HDL; thus, 
determined as risk factor for coronary heart 
disease.43 
 
Factors affecting apolipoprotein B 
There are several factors that cause an increase in 
apo B including nutritional factors (nutritional 
status, dietary fibers, fat, and carbohydrates) and 
non-nutritional factors (age, gender, physical 
activity, and smoking habits). 
 
1. Nutritional status 
Obesity is one of the risks of cardiovascular disease 
due to its relationship with high triglycerides, LDL 
cholesterol, low HDL cholesterol, increased blood 
glucose, insulin resistance and hypertension. New 
findings regarding metabolic risk factors associated 
with fat and obesity are the presence of a small dense 
LDL phenotype, postprandial hyperlipidemia with 
atherogenic accumulation and excessive 
lipoproteins production containing apolipoprotein 
B. These lipid disorders are characteristic of 
metabolic syndrome and is associated with an 
inflammation which partly due to the adipose tissue 
itself. An important relationship between obesity, 
metabolic syndrome and dyslipidemia, is insulin 
resistance in peripheral tissues that leads to 
increased liver fatty acids from food sources, 
 
World.Nutr.Journal | 78  
intravascular lipolysis and from adipose tissue 
resistance to the antilipolytic effect of insulin.44 
 
2. Diet pattern 
Study in 28,984 Swedish individuals showed a 
significant correlation between dietary fiber intake 
and apolipoprotein B.21 Another clinical trial by 
Ramos et al.20 in 116 people with 
hypercholesterolemia showed that apoB levels in the 
group fed with fiber significantly lower after after 12 
weeks. Additionally, study by Anggadiredja et al.45 
in 41 individuals with hypercholesterolemia showed 
that 4 weeks of fibers supplement treatment affects 
apolipoprotein B levels.  
 
3. Age and gender 
Research conducted by Anagnostis et al.46 showed 
that advancing age is positively associated with 
increased levels of apolipoprotein B. Those study 
also explains that at the age of 50-55 years, men 
generally have a higher average apolipoprotein B 
than women.  
 
4. Smoking habits 
Smoking is one of the causes of heart attacks. 
Nicotine causes the secretion of catecholamines, 
cortisol, and growth hormone, which results in 
adenyl cyclase activation in the adipose tissue. 
Lipolysis will be initiated from triglycerides and 
fatty acids will be secreted into the plasma. 
Circulating fatty acids binds with albumin and 
results in increased synthesis of triglycerides and 
VLDL in the liver. Thus, results in increasing 
triglycerides and VLDL and decreasing HDL. Since 
apolipoprotein B is required to produce LDL and 
VLDL, high levels of LDL and VLDL is associated 
with high apolipoprotein B.47 
 
5. Physical activity  
Study revealed that months of aerobic exercise 
decreased apoB concentration in 
hypercholesterolemic men.48 In contrast, another 
study by reported that aerobic exercise for 20 weeks 
did not affect the concentration of apoB. Others 
found no change in apoB concentrations during 
either long or short aerobic exercise. Some factors 
must result in these various outcomes such as age.49  
 
 
Association between apolipoprotein B and dietary 
fibers 
 
Dietary fiber has been studied by various researchers 
to provide evidences of its beneficial effect in 
lowering cholesterol levels. The increased risk of 
cardiovascular disease has a positive correlation 
with the improvement of LDL cholesterol levels.50 
Soluble fiber has a positive effect on apoB levels in 
respect of preventing cardiovascular disease. ApoB 
is the dominant lipoprotein component in LDL 
particles, which is also found in VLDL and IDL. 
ApoB have been proposed as a marker to quantitate 
the atherogenic damage, due to the fact that it is the 
component constituent of the atherogenic particles; 
hence, plasma apoB levels reflect the total numbers 
of atherogenic particles.25,51 Research on the 
association of ApoB levels and dietary fibers intake 
shows controversial results (Table 3). This may be 
due to differences in the characteristics of the 
subject, especially in the source of food and 
metabolism in the body in various populations. 
Two studies did not find associations between 
dietary fiber and serum apoB, while other seven 
found the association. Dietary fiber has been widely 
reported to be involved in the metabolism of serum 
cholesterol (both atherogenic and non-atherogenic) 
and blood pressure; hence, the deficiency of dietary 
fiber intake is believed to contribute to the epidemic 
of cardiovascular diseases. Several factors including 
nutritional status, dietary diet pattern, age, gender, 
physical activity, and smoking habits might 
influence the relationship between dietary fiber and 
serum apoB; thus, explaining the different results. 
The clinical utility of apoB is of the most value in 
populations such as those with obesity and type 2 
diabetes in whom the risk of CVD is elevated.58 
Trapping of apoB particles drives the atherosclerotic 
process from beginning to end.59 Cholesterol is a 
critical component of the apoB particles within the 
arterial wall. The mass of cholesterol within plasma 
does correlate positively with the number of apoB 
particles within plasma. But variance in the mass of 
cholesterol per apoB particle produces variance in 
the relation between cholesterol and apoB and 
therefore a difference in the relation of each to risk.60 
EAS and EFLM accept that cardiovascular risk 
relates more closely to apoB than to LDL-C/non-
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HDL-C; therefore, the clinical utility of apoB 
exceeds LDLC/non-HDL-C.61,62 
Unfortunately, there are still few studies that did 
not find associations between dietary fiber and 
serum apoB one of which is study by Ho et al.53. 
Interestingly study by Ho et al.53  showed that konjac 
glucomannan did not appear to significantly affect 
the overall effect estimate for apoB, the reduction of 
0.05 g/L is higher than that reported in the previous 
reported meta-analysis of oats (−0.03 g/L) and 
barley (−0.03 g/L) β-glucans by Ho et al.55. 
Therefore, more studies are required to better 
understand the role of konjac glucomannan and β-
glucans on apoB, specifically the mechanism of 




The results of the studies on the relationship between 
dietary fibers and serum apoB levels have been 
inconsistent; while some studies found the negative 
correlation between dietary fibers and serum apoB 
levels, others did not. Dietary fiber has been widely 
reported to be involved in the metabolism of serum 
cholesterol (both atherogenic and non-atherogenic) 
and blood pressure; hence, the deficiency of dietary 
fiber intake is believed to contribute to the epidemic 
of cardiovascular diseases. Several factors including 
nutritional status, dietary diet pattern, age, gender, 
physical activity, and smoking habits might 
influence the relationship between dietary fiber and 
serum apoB; thus, explaining the different results.  
More studies are required in the future for better 
understanding on the effect of dietary fiber on the 





Table 1. Dietary fiber content of various food sources24 
Food Sources Soluble Dietary 
Fiber (g/100 g) 
Insoluble Dietary Fiber 
(g/100 g) 
Total 
Fruits (raw)    
Apple with skin 0.70 2.00 2.70 
Banana 0.58 1.21 1.79 
Grape 0.24 0.36 0.60 
Mango 0.69 1.08 1.76 
Orange 1.37 0.99 2.35 
Pear with skin 0.92 2.25 3.16 
Pineapple 0.04 1.42 1.46 
Strawberry 0.60 1.70 2.30 
Watermelon 0.13 0.27 0.40 
Beans (cooked)    
Black beans   8.7 
Red beans 1.36 5.77 7.13 
Nuts    
Almonds   12.3 
Peanuts   8.1 
Vegetables (cooked)    
Broccoli 1.85 2.81 4.66 
Carrot 1.58 2.29 3.87 
Lettuce (raw)   1.3 
Corn   2.0 
Mushroom   2.4 
Cooked potatoes with skin 0.61 1.70 2.31 
Steamed potato, skinless 0.99 1.06 2.05 
Grains and Products    
Rice (cooked)    
White   0.3 
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Food Sources Soluble Dietary 
Fiber (g/100 g) 
Insoluble Dietary Fiber 
(g/100 g) 
Total 
Red   1.8 
Bread    
White   2.4 
Wheat   6.8 
Cereal (cold)    
All rice bran   29.3 
Raisin skin   11.1 
Corn flakes   2.5 
Wheat biscuits   10.6 
 
 
Table 2. Recommended fiber intake in Indonesia and the United States 
Gender Age (year) Recommended fiber intake (gram) 
Indonesia United State 
Man 19 – 29 37 38  30-49 36 
 ³ 51  31 
Woman 19 – 29 32 25  30-50 30 
 ³ 51  21 
 
Table 3. Characteristics of studies on the association between apoB and dietary fibers 
Author Study Design Subjects Results/Conclusion 
Yulia et al. 
(2016)52 
Double blind randomized 
clinical trial with parallel 
design 
28 individuals with obese I 
(BMI of 25-29.9 kg/m2), 
aged 30-50 years. 
Psyllium husk fiber 8.4 g/day 
and low-calorie balanced diet 
1200 kcal/day in obese I 
individuals did not reduce apo 
B level in 4 weeks 
Ho et al. 
(2017)53  
Meta-analysis study 12 publications (n = 370) 
were included. Six trials 
reported on apoB (n = 162). 
Results from 6 studies did 
not show any effect of konjac 
glucomannan, a viscous 
soluble fiber, on apoB 
Antoniazzi et 
al. (2019)54  
Population-based 
observational study 
190 individuals with 
heterozygous familial 
hypercholesterolemia 
Inverse association was 
encountered between fibers 
with ApoB 
Ho et al. 
(2016)55 
Meta-analysis study Fifty-eight trials (n 3974) 
retrieved from MEDLINE, 
Embase, CINAHL and 
Cochrane CENTRAL 
assessing the effect of oat β-
glucan diets compared with 
controlled diets apoB. 
Oat β-glucan, a viscous, 
soluble fibre, has a lowering 
effect on apoB 
 





73 subjects with abdominal 
obesity (abdominal 
circumference ≥80 cm for 
women or ≥94 cm for men) 
age ≥40 years.  
Low-fiber cereal consumption 
for 12 weeks reduced fasting 
apolipoprotein B. 
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Author Study Design Subjects Results/Conclusion 
Frondelius et 
al. (2017)21 
Population-based cohort 74,318 healthy individuals, 
men and women aged 44–74 
years between 1991 and 
1996 
There was a significant 
correlation between dietary 
fiber intake and apolipoprotein 
B. 
Ramos et al. 
(2011)20 
Randomized, parallel-
design study with blinded 
endpoints 
Subjects with primary 
hypercholesterolemia (n= 
116). 
ApoB levels in the group fed 
with fiber significantly lower 
after after 12 weeks 
Anggadiredja 




participants (fasting LDL-c 
concentration of > 130 
mg/dL), 18 years of age  
Four weeks of fibers 
supplement treatment 
significantly affects 
apolipoprotein B levels. 
Jovanovski et 
al. (2018)57 
Meta-analysis study 28 trials (n = 1924) retrieved 
from Medline, EMBASE, 
CINAHL, and the Cochrane 
Central Register of 
Controlled Trials 
Supplementation of Psyllium 
fiber effectively improves apoB 
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